Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)

IRB/UVA Tracking #
17720
Contact First Name

Gracie Tubbs Hockenberry

Contact Email
Contact Phone
Phase
III
Primary purpose
Treatment
Cancer PI
Richard Hall
Status
OPEN TO ACCRUAL